LEADOPTIK Announces First-In-Human Use Of FDA-Cleared LIATM System. SAN JOSE, Calif., Feb. 5, 2026 /PRNewswire/ -- LEADOPTIK, Inc., a medical technology company focused on advancing precision lung ...

LEADOPTIK, Inc., a medical technology company focused on advancing precision lung cancer biopsy, today announced the ...

Leadoptik today announced the successful first-in-human clinical use of its FDA-cleared Last Inch Assessment (LIA) system.

Foundation works to spread awareness after personal loss drives mission ...

Conservative commentator Victor Davis Hanson revealed on Monday that he is uncertain when he will make a full recovery after ...

Traction bronchiectasis on computed tomography and body mass index were significantly associated with PPF, while radiological and symptomatic progression and older age were significantly associated ...

Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use ...

A key outcome from lung cancer screening studies is the concept of ‘stage-shift’ seen in screen-detected cancers compared ...

Stage 1 lung carcinoid tumors are confined to the lung and have not spread to lymph nodes or distant organs. Tumors at this stage are typically small and localized, which often allows for curative ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node ...

EAST LANSING, Mich. (WLNS) — As a person who has struggled with a cigarette addiction for more than 40 years, annual low-dose ...

Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that combines Optellum's AI-driven lung cancer risk stratification with ...